메뉴 건너뛰기




Volumn 3, Issue 2, 2008, Pages 206-221

The treatment of dyslipidemia - What's left in the pipeline?

Author keywords

Fatty acids; Lipids; Lipoproteins; PPAR

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER TRANSFER PROTEIN; CLOFIBRIC ACID; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; SQUALENE SYNTHASE; TRIACYLGLYCEROL;

EID: 47649107796     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200700165     Document Type: Review
Times cited : (16)

References (169)
  • 2
  • 84
    • 54549120989 scopus 로고    scopus 로고
    • NJ USA, Merck & Co, available online at
    • I. N. U. Bristol-Myers Squibb Company, NJ (USA); Merck & Co., 2005, available online at http://www.fda.gov.
    • (2005) Company
    • Bristol-Myers Squibb, I.N.U.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.